trial
as of 2026-07-01Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
NCTId NCT01242371
at a glance
— · Completed
Enrollment 65 (actual)
Sponsored by Sheppard Pratt Health System
Primary completion 2012-08
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
65 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2010-08
Primary completion
2012-08
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Sheppard Pratt Health SystemLead Sponsor
Stanley Medical Research InstituteCollaborator
Investigators
1
Faith B Dickerson, PhD, MPHPrincipal Investigator
Sites
1 total
Towson, United States
Facts & assertions
4 sourced
Enrollment
65
Phase
NA
Primary Completion Date
2012-08
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
investigator